Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 4.5 Exhibit 4.5
- 4.6 Exhibit 4.6
- 4.7 Exhibit 4.7
- 4.8 Exhibit 4.8
- 4.9 Exhibit 4.9
- 4.10 Exhibit 4.10
- 4.11 Exhibit 4.11
- 4.12 Exhibit 4.12
- 4.13 Exhibit 4.13
- 4.14 Exhibit 4.14
- 5.1 Exhibit 5.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 25.1 Exhibit 25.1
- 99.1 Exhibit 99.1
CI similar filings
- 28 May 20 Registration of securities issued in business combination transactions
- 23 Jul 19 Registration of securities issued in business combination transactions (amended)
- 21 Jun 19 Registration of securities issued in business combination transactions
- 13 Jul 18 Registration of securities issued in business combination transactions (amended)
- 12 Jul 18 Registration of securities issued in business combination transactions (amended)
- 9 Jul 18 Registration of securities issued in business combination transactions (amended)
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-4 of Cigna Corporation of our report dated February 27, 2018, relating to the financial statements of Express Scripts Holding Company, which appears in Cigna Corporation’s Current Report on Form 8-K dated March 8, 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
St. Louis, Missouri
June 21, 2019
St. Louis, Missouri
June 21, 2019